Infographic Targeting hepatitis C — how new treatments work There are >185 million people with hepatitis C infection worldwide but new treatments mean that most people with access to therapy can now be cured. …Published: 28 January 2016
Opinion Top 10 news stories for 2015 Drug safety was a hot topic in 2015, accounting for five of the top 10 news stories consumed by our readers.…Published: 25 January 2016
News Antihistamine reduces pain in irritable bowel syndrome Patients given H1 antihistamine ebastine showed significant reduction in pain score in randomised trial.…Published: 22 January 2016
News PPI use increases risk of chronic kidney disease by as much as 50% Proton pump inhibitors — used to inhibit gastric acid secretion — are associated with a 20–50% increase in the risk of developing chronic kidney disease, according to new research.…Published: 13 January 2016
Feature Coeliac disease: getting the measure of new drug treatments As more people are being diagnosed with coeliac disease, the first drug treatments are entering clinical trials, but success is proving difficult to measure.…Published: 13 November 2015
News Proton pump inhibitors linked with chronic kidney disease A growing body of evidence has linked proton pump inhibitors with acute kidney injury and now new research has also found links with chronic kidney disease.…Published: 30 October 2015
News Department of Health reports 5.2% growth in spending on branded drugs NHS spending on branded drugs made available under the Pharmaceutical Price Regulation Scheme between 2013 and 2014 went up by 5.2%, according to a new analysis.…Published: 14 September 2015
News Proton pump inhibitors linked with low risk of lupus, says UK regulator Proton pump inhibitors have been linked with rare cases of subacute cutaneous lupus erythematosus, according to a drug update issued by the Medicines and Healthcare products Regulatory Agency.…Published: 11 September 2015
Feature Specialist roles in hospital pharmacy Pharmacy professionals have the opportunity to specialise in a variety of clinical areas. Eamonn McArdle explores the possibilities.…Published: 4 September 2015
